Live from the NIH registry
Studies recruiting near Canton right now
Top 25 of 307 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (0.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Canton, Ohio (0.8 mi)
· Sponsor: AstraZeneca
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cleveland Clinic - Mercy Hospital ( Site 0057) — Canton, Ohio (0.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Duke University
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-008 — Canton, Ohio (0.8 mi)
· Sponsor: Biohaven Therapeutics Ltd.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Primary Mitochondrial Disease
Phase 2
Interventional 180 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: Pharming Technologies B.V.
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (24.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 714 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: Pfizer
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Neuro-Behavioral Clinical Research — North Canton, Ohio (5.0 mi)
· Sponsor: Bristol-Myers Squibb
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Lipidemia, Type 2 Diabetes (T2DM)
Phase 3
Interventional 300 participants sought
Summit Research Group — Munroe Falls, Ohio (23.6 mi)
· Sponsor: NewAmsterdam Pharma
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Akron, Ohio (20.5 mi)
· Sponsor: Medtronic
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (0.8 mi)
· Sponsor: NRG Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Novo Nordisk A/S
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Cleveland Clinic Wooster Family Health and Surgery Center — Wooster, Ohio (29.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 315 participants sought
Childrens Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: H. Lundbeck A/S
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
Solid Tumor
Phase 1, Phase 2
Interventional 70 participants sought
Gabrail Cancer Center — Canton, Ohio (0.8 mi)
· Sponsor: Lamassu Bio Inc
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Breast Cancer, Metastatic
Phase 2
Interventional 120 participants sought
Gabrail Cancer Center — Canton, Ohio (0.8 mi)
· Sponsor: ALX Oncology Inc.
Two Dose Levels of Privigen in Pediatric CIDP
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 4
Interventional 30 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: CSL Behring
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Lung Cancer, Non-small Cell, Lung Cancer Metastatic
Phase 1, Phase 2
Interventional 250 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: Krystal Biotech, Inc.
Pro-2-Cool Pivotal Trial II
Concussion, Mild
N/A
Interventional 66 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: TecTraum Inc.